ZIOPHARM Oncology, Inc. (ZIOP) Tops Q2 EPS by 3c

August 1, 2011 6:31 AM EDT
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q2 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings